Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Bayer plc
Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
Telephone: +44 (0)1635 563 000
Fax: +44 (0)1635 563 393
WWW: http://www.bayer.co.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 17/04/2012
PIL Adalat LA 60 mg prolonged-release tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/04/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
Updated on 03/02/2012 and displayed until 17/04/2012
Reasons for adding or updating:
  • Change to dosage and administration
Updated on 13/08/2010 and displayed until 03/02/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change of contra-indications
Updated on 06/05/2010 and displayed until 13/08/2010
Reasons for adding or updating:
  • Extra statutory information
Updated on 07/04/2009 and displayed until 06/05/2010
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 28/10/2008 and displayed until 07/04/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 30/06/2008 and displayed until 28/10/2008
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 26/02/2008 and displayed until 30/06/2008
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 24/01/2008 and displayed until 26/02/2008
Reasons for adding or updating:
  • Change due to harmonisation of patient information leaflet
Updated on 25/10/2006 and displayed until 24/01/2008
Reasons for adding or updating:
  • Change to instructions about overdose
  • Change to date of revision
Updated on 28/07/2006 and displayed until 25/10/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to instructions about missed dose
  • Change to date of revision
Updated on 15/03/2005 and displayed until 28/07/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 20/01/2005 and displayed until 15/03/2005
Reasons for adding or updating:
  • Change of manufacturer
Updated on 23/01/2004 and displayed until 20/01/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 05/11/2002 and displayed until 23/01/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 25/09/2001 and displayed until 05/11/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 27/06/2000 and displayed until 25/09/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  nifedipine